Risk of cancer development associated with disease-modifying therapies for multiple sclerosis: study protocol for a systematic review and meta-analysis of randomised and non-randomised studies

Peer Review reports

Original Submission
26 Mar 2024	Submitted	Original manuscript
24 Sep 2024	Reviewed	Reviewer Report - Craig Lockwood
25 Sep 2024	Author responded	Author comments - Ferrán Catalá-López
Resubmission - Version 2
25 Sep 2024	Submitted	Manuscript version 2
Publishing
4 Oct 2024	Editorially accepted
18 Oct 2024	Article published	10.1186/s13643-024-02677-z

Back to article page